ArticleNeuro-oncology practice2025
Phase 1 study of mebendazole therapy for refractory/progressive or recurrent pediatric brain tumors.
Paul Phan et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it